ArticleOncotarget2016

Liquid biopsy monitoring uncovers acquired RAS-mediated resistance to cetuximab in a substantial proportion of patients with head and neck squamous cell carcinoma.

Friederike Braig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.